The content is available as a PDF (822.3 KB).
. 2021 Apr 24:gfab165. doi: 10.1093/ndt/gfab165
Efficacy of the BNT162b2 mRNA Covid-19 Vaccine in a hemodialysis cohort
Luc Frantzen
1,✉, Guilhem Cavaille
1, Sandrine Thibeaut
2, Yohan El-Haik
3
Luc Frantzen
1
Service de Néphrologie, Hôpital Saint Joseph Marseille, France
Find articles by Luc Frantzen
Guilhem Cavaille
1
Service de Néphrologie, Hôpital Saint Joseph Marseille, France
Find articles by Guilhem Cavaille
Sandrine Thibeaut
2
Laboratoire de Biologie Médicale, Hôpital Saint Joseph Marseille, France
Find articles by Sandrine Thibeaut
Yohan El-Haik
3
Pharmacie, Centre de Dialyse DIAVERUM Marseille Hôpital Saint Joseph, France
Find articles by Yohan El-Haik
1
Service de Néphrologie, Hôpital Saint Joseph Marseille, France
2
Laboratoire de Biologie Médicale, Hôpital Saint Joseph Marseille, France
3
Pharmacie, Centre de Dialyse DIAVERUM Marseille Hôpital Saint Joseph, France
✉
Correspondence to: Luc FRANTZEN; E-mail: lfrantzen@mac.com
Received 2021 Apr 19.
© The Author(s) 2021. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
PMCID: PMC8135401 PMID: 34450646